NDC 0409-1623
Butorphanol Tartrate
Butorphanol Tartrate
Butorphanol Tartrate is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Butorphanol Tartrate.
Product ID | 0409-1623_695b7874-f6f9-4a28-8d0d-4d91f9ad3bd4 |
NDC | 0409-1623 |
Product Type | Human Prescription Drug |
Proprietary Name | Butorphanol Tartrate |
Generic Name | Butorphanol Tartrate |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2005-09-23 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA074626 |
Labeler Name | Hospira, Inc. |
Substance Name | BUTORPHANOL TARTRATE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |